Vital Signs - Big Science - Big Data - Big CollaborationCancer Research in a Virtual Frontier

 

USD 1,500

* Required Fields

USD 1,500

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on March 26, 2012, provides a strategic insight on critical tools and mechanisms that accelerate knowledge discoveries along the translational cancer research continuum.

Additionally, a company spotlight is provided for SoloHealth. While self-service healthcare is by no means new, with blood pressure kiosks being around for decades, the self-service healthcare industry is primed for significant advances. SoloHealth is directly participating in this transformative time for self-service healthcare by providing a cutting-edge line of next-generation healthcare kiosks.

Reimbursement and regulatory news from the FDA is also provided for week of March 6, 2012.

Table of Contents

Vital Signs - Big Science - Big Data - Big Collaboration…Cancer Research in a Virtual FrontierVital Signs: 26 March 2012This week's issue




Related Research

Release Date : 26-Sep-17

Region : North America

Release Date : 25-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 08-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.